Tapewire

Nasdaq · USD

GOVX

GeoVax Labs, Inc.

Export transactions ↓
Tapewire entity
8419
SEC CIK
0000832489
Parsed reports
116

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2018 Filed Sep 5, 2018 21:30 UTC
DODD DAVID ADirector · President, CEO
GrantStock Purchase Option · Derivative 3,000,000 $0.00 Strike: $0.03 $0.00
Disclosure

SEC source: 0001437749-18-016632 · rdgdoc.xml · derivative · entry 1

DODD DAVID A · CIK 0001193607 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2028-09-01

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:25 UTC GrantCommon Stock Purchase Option · Derivative 170,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021101 · rdgdoc.xml · derivative · entry 1

Kollintzas Dean G · CIK 0001378351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:25 UTC GrantCommon Stock Purchase Option · Derivative 240,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021100 · rdgdoc.xml · derivative · entry 1

SPENCER JOHN N JR · CIK 0001270555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,000

Underlying: Common Stock · 240,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:25 UTC
DODD DAVID ADirector
GrantCommon Stock Purchase Option · Derivative 270,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021098 · rdgdoc.xml · derivative · entry 1

DODD DAVID A · CIK 0001193607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 270,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:25 UTC GrantCommon Stock Purchase Option · Derivative 200,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021099 · rdgdoc.xml · derivative · entry 1

CHASE RANDAL D · CIK 0001078784 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:25 UTC
ROBINSON HARRIET LDirector · CSO Emeritus
GrantCommon Stock Purchase Option · Derivative 450,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021097 · rdgdoc.xml · derivative · entry 1

ROBINSON HARRIET L · CIK 0001377780 · Director · CSO Emeritus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:24 UTC
Guirakhoo FarshadChief Scientific Officer
GrantCommon Stock Purchase Option · Derivative 500,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021096 · rdgdoc.xml · derivative · entry 1

Guirakhoo Farshad · CIK 0001656602 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:22 UTC
MCNALLY ROBERT TDirector · President/CEO
GrantCommon Stock Purchase Option · Derivative 750,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021095 · rdgdoc.xml · derivative · entry 1

MCNALLY ROBERT T · CIK 0001049435 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 20, 2017 Filed Dec 22, 2017 16:22 UTC GrantCommon Stock Purchase Option · Derivative 750,000 $0.00 Strike: $0.05 $0.00
Disclosure

SEC source: 0001437749-17-021094 · rdgdoc.xml · derivative · entry 1

Reynolds Mark · CIK 0001298237 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2027-12-20

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:25 UTC GrantCommon Stock Purchase Option · Derivative 106,700 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043419 · rdgdoc.xml · derivative · entry 1

CHASE RANDAL D · CIK 0001078784 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,700

Underlying: Common Stock · 106,700 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:32 UTC
DODD DAVID ADirector
GrantCommon Stock Purchase Option · Derivative 202,800 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043430 · rdgdoc.xml · derivative · entry 1

DODD DAVID A · CIK 0001193607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,800

Underlying: Common Stock · 202,800 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:37 UTC GrantCommon Stock Purchase Option · Derivative 123,500 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043432 · rdgdoc.xml · derivative · entry 1

SPENCER JOHN N JR · CIK 0001270555 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,500

Underlying: Common Stock · 123,500 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:33 UTC GrantCommon Stock Purchase Option · Derivative 79,275 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043431 · rdgdoc.xml · derivative · entry 1

Kollintzas Dean G · CIK 0001378351 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,275

Underlying: Common Stock · 79,275 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:31 UTC
ROBINSON HARRIET LDirector · Chief Scientific Officer
GrantCommon Stock Purchase Option · Derivative 262,200 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043429 · rdgdoc.xml · derivative · entry 1

ROBINSON HARRIET L · CIK 0001377780 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,200

Underlying: Common Stock · 262,200 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:29 UTC
MCNALLY ROBERT TDirector · President/CEO
GrantCommon Stock Purchase Option · Derivative 462,500 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043427 · rdgdoc.xml · derivative · entry 1

MCNALLY ROBERT T · CIK 0001049435 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 462,500

Underlying: Common Stock · 462,500 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:27 UTC
Guirakhoo FarshadSr VP, Research & Development
GrantCommon Stock Purchase Option · Derivative 85,000 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043423 · rdgdoc.xml · derivative · entry 1

Guirakhoo Farshad · CIK 0001656602 · Sr VP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:28 UTC
Guirakhoo FarshadSr VP, Research & Development
GrantCommon Stock Purchase Option · Derivative 85,000 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043424 · rdgdoc.xml · derivative · entry 1

Guirakhoo Farshad · CIK 0001656602 · Sr VP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document
December 13, 2016 Filed Dec 15, 2016 21:26 UTC GrantCommon Stock Purchase Option · Derivative 335,000 $0.00 Strike: $0.07 $0.00
Disclosure

SEC source: 0001437749-16-043421 · rdgdoc.xml · derivative · entry 1

Reynolds Mark · CIK 0001298237 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,000

Underlying: Common Stock · 335,000 shares

Expires 2026-12-13

F1 · derivative.exercise_date: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.